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Abstract 
Preterm infants on the Neonatal Intensive Care 
Unit receive a greater number of red cell transfusions 
than any other hospitalised group. Over the past 
twenty years research has focused on setting standards 
to determine when it is necessary to transfuse packed 
cells in this cohort, whilst exploring the use of red cell 
growth factors and other substrates judiciously in order 
to reduce and/or avoid red cell transfusions and limit 
donor exposure. One hundred and eighty-one blood 
transfusions were administered to 106 preterms less 
than 35 weeks gestation on the NICU during 2009 in 
Malta. The median (range) volume of blood used from 
each bag supplied by the Blood Transfusion 
Department was 25.8mls (10-50mls), the rest of which 
was discarded. Risk factors for transfusion included 
Extremely Low Birth Weight (less than 1kg) and a 
gestation of less than 30 weeks. The blood transfusion 
guidelines presently in use on the local NICU were 
reviewed and compared with more restrictive 
guidelines on other units and suggestions made to 
reduce transfusions in line with these guidelines.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A reduction in transfusion aliquots provided for 
neonates to just 50mls from the customary 250mls in a 
dedicated single-donor programme will safeguard 
limited health resources and minimise donor exposure. 
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Introduction 
Preterm infants on the neonatal intensive care unit 
(NICU) receive a greater number of red cell 
transfusions (RCTs) than any other hospitalised 
group.
1
 During the first weeks after birth when blood 
sampling is frequent, approximately 50% of extremely 
low birth weight (ELBW) infants receive their first 
transfusion.
1
 By the time of discharge, approximately 
85% of ELBW infants would have been transfused. 
A RCT aims to provide an immediate increase in 
oxygen delivery to tissues. Oxygen delivery can be 
increased by a RCT or by administering red cell 
growth factors (RCGF). Although the risk of 
transmission of known infectious agents (eg hepatitis 
B and C virus, human immunodeficiency virus) is 
relatively low, the risk of infectious agents newly 
identified in transfused blood (eg Plasmodium sp, 
Parvovirus B19) remains to be determined.
2
  
Research to evaluate the efficacy of restrictive 
transfusion guidelines have lead to strategies to 
decrease RCTs in preterms.
3
 Controversy surrounds 
the haemoglobin value and clinical circumstances 
under which RCTs should be administered. If a 
preterm with a low haematocrit needs an immediate 
increase in oxygen to tissues then a RCT is required 
otherwise treatment with RCGF and appropriate 
substrates such as folic acid and oral iron should be 
considered. Limiting donor exposure is prudent for 
infants who are likely to receive multiple transfusions.
4
 
Single-donor programmes limit donor exposure, cost 
less and lead to better preservation of limited blood 
resources without incurring additional risk. This 
programme involves dedicating an adult bag of red 
cells to a particular preterm by dividing the volume 
into aliquots for use by this preterm.  
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Our study was designed to quantify the number of 
RCTs administered to preterms less than 35 weeks 
gestation, and to identify the cohort by birth weight 
and by gestation that was most likely to require 
repeated transfusions and would, therefore, benefit 
from a single-donor transfusion programme. The ideal 
volume of blood in each aliquot to make best use of 
resources was determined. Finally, the number of 
transfusions administered according to the local 
guidelines was compared with the number required if 
more restrictive guidelines were applied. 
Methods 
A prospective study on the NICU was carried out 
between 1
st
 January and 31
st
 December 2009.  
Gestational age, birth weight, date of 
admission/discharge, any complications of prematurity 
including periventricular leucomalacia, intraventricular 
haemorrhage, chronic lung disease, necrotising 
enterocolitis, retinopathy of prematurity and any 
surgical intervention were recorded. The number of 
days on ventilatory support, nasal continuous positive 
airway pressure (nCPAP), nasal prong oxygen and 
with umbilical arterial/venous access or peripheral 
arterial access, were documented for each infant. 
For each transfusion administered we noted the 
date, gestation and weight at transfusion; whether the 
baby was symptomatic with poor feeding, tachycardia, 
bradycardia, apnoeas/desaturations; the need for 
inotropes; the mode of ventilation and any 
improvement post-transfusion, as well as the amount 
in millilitres of blood transfused/discarded, and 
haemoglobin pre- and post- transfusion. 
 
Results 
RCT by birth weight and gestation (Table 1). 
 
Table 1: RCT by birth weight 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 preterms less than 35 weeks gestation were 
admitted during the study period. 12 (92%) ELBW 
babies were transfused; 12 (55%) VLBW babies 
required a transfusion; 15 (25%) LBW preterms were 
transfused and 1 (8%) preterm less than 2.5kg was 
transfused. The most heavily transfused were the 
ELBW babies, followed by those of VLBW. 8% of 
preterms were between 24-26 weeks gestation and, of 
these, 75% required a RCT. 12% were between 27-29 
weeks and all required a RCT. In comparison, 28% 
were between 30-32 weeks gestation and 50% required 
a RCT, whereas 52% were between 33-35 weeks and 
only 7% of these required a RCT (Table 2). These data 
show that babies less than 30 weeks gestation are the 
most heavily transfused. 
Table 2: RCT by gestational age 
 
 
 
 
 
 
 
 
 
 
RCTs in individual preterms by birth weight 
(Figure 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: number of RCT by birth weight 
 
All infants less than 1000g required 4 or more 
RCTs (with the exception of two babies, one of whom 
was recruited in the last days of the study and data 
from 2010 was omitted, and another who died within a 
few hours from birth). 80% of babies less than 1500g 
had 2 or more transfusions. Most preterms greater than 
1501g required only one blood transfusion. The cohort 
most highly transfused and most likely to benefit from 
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a single-donor transfusion programme included 
preterms weighing less than 1500g. 
 
RCTs in individual preterms by gestational age 
(Figure 2)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Number of RCT by gestation 
 
All infants between 24-26 weeks had 4 or more 
RCTs, whilst 77% of those between 27-29 weeks 
received more than 4 RCTs. 56% of 30-32 week 
gestation babies received more than 2 RCTs, and all 
preterms greater than 33 weeks gestation had one 1 
RCT. Thus preterms less than 32 weeks gestation are 
most highly transfused and would benefit from having 
a single-donor programme. 
Determination of best aliquot size (Figure 3) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Volume of red cells required for each 
transfusion 
 
The total number of RCTs administered during 
the study period was 181. Each volume transfused was 
20mls/kg body weight. The mean (mode, range) 
volume of packed cells transfused was 25.8mls (20mls, 
10-50mls). During the study period, at least 150-
200mls of blood per bag was discarded.  
In this study ‘high-risk’ preterms less than 32 weeks 
gestation received 162 bags of red cells. However, if a 
single-donor transfusion programme was in operation, 
only 56 bags (assuming 5 aliquots of 50ml per 250ml 
bag) would have been required. This would translate in 
a net reduction of 106 bags (65% less). 
Comparison of transfusion guidelines 
Each neonatal unit has its own transfusion 
guidelines. Using local criteria (Table 3) 156 (86%) 
transfusions were required in oxygen-dependent 
preterms (70 in ventilated preterms, 61 in preterms on 
nCPAP, 25 in preterms on nasal prong oxygen), whilst 
25 (14%) were required in preterms in room air (23 
babies were asymptomatic, 1 was feeding poorly, 1 
had apnoeas/oxygen desaturations). 
 
Table 3: Recommendations for the administration 
of RCT in preterm infants in Malta 
Criteria for administering 
packed RCT 
Hb Level 
Neonates who are in oxygen, 
whether ventilated, on nasal CPAP 
or using nasal prongs 
< 12g/dL 
Neonates who are not in oxygen 
and who have a reticulocyte count 
of < 100 000/uL 
< 10g/dL 
 
Comparison with British transfusion guidelines 
5 
for neonates receiving intensive care showed that the 
same number of transfusions would have been 
required. We equated chronic oxygen dependency in 
the British guidelines to nCPAP/nasal prong oxygen in 
the local guideline. Using British criteria (Table 4), 34 
less transfusions would have been required (86 
transfusions given locally to babies on nCPAP/nasal 
prongs vs. 52 if British criteria were used).  
 
Table 4: Recommendations for RCT in preterm 
infants proposed by the British Standards in 
Haematology Transfusion Task Force 2009 
Criteria for administering 
packed RCT 
Level 
Anaemia in the first 24h Hb < 12 g/dL 
Cumulative blood loss in 1 
week, receiving intensive care 
10% blood 
volume 
Neonate receiving intensive 
care 
Hb < 12 g/dL 
Acute blood loss 10% blood 
volume 
Chronic oxygen dependency Hb < 11 g/dL 
Late anaemia, stable patient Hb < 7 g/dL 
 
Late anaemia in the stable patient by British standards 
was equated to asymptomatic babies in room air: 9 less 
transfusions would have been given (23 vs. 14) in this 
subgroup. Using a single-donor system and restrictive 
guidelines in clinically stable preterms would translate 
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in an overall further total reduction of 4 bags. An 
attempt was made to correlate the presence of 
indwelling arterial/central venous lines with increased 
risk for RCT due to increased phlebotomy losses but 
the number was too small and there were too many 
confounding factors to draw any conclusions.  
 
Discussion 
181 RCTs were administered to preterms during 
the study period. The most heavily transfused were 
preterms between 24-29 weeks gestation closely 
followed by those between 30-32 weeks gestation and 
those less than 1000g closely followed by those 
weighing 1001-1500g. Thus, a gestation of less than 
32 weeks and weight of less than 1.5kg are the major 
risk factors for transfusion.  
This study shows that aliquots of 50mls of blood 
would be adequate. With this practice the number of 
donor units required can be reduced by 65% leading to 
more cost-effective use of this limited resource.  
With a single-donor programme high-risk 
preterms are identified, and the Blood Transfusion 
Department will dedicate a set of aliquots, reducing 
the risks of donor exposure.  
Adopting restrictive guidelines on our NICU, as is 
the trend in Europe, Canada and the US 
6
 would 
translate into a smaller number of transfusions without 
any additional risks to babies. Indeed, comparison with 
these guidelines shows that for intensive care babies 
the present protocol of transfusing when the 
haemoglobin is below 12g/dL is recommended by both. 
However, it would appear to be safe practice to adopt 
more restrictive transfusion guidelines in the more 
stable, chronic cohort. Two randomized clinical trials 
have addressed the controversy of whether restrictive 
or liberal RCT criteria should be applied in infants
7, 8
. 
Bell et al showed that although neonates transfused 
using restrictive criteria required fewer RCTs they did 
have significantly more apnoea, intraparenchymal 
brain haemorrhage and periventricular leukomalacia.
9
 
Thus, it is postulated that the higher haemoglobin 
values confer protection against apnoea and brain 
injury. On the other hand, in the PINT study, Kirpalani 
et al showed that maintaining a higher haemoglobin 
level in ELBW babies results in more infants receiving 
transfusions without any additional benefit.
7
 These 
same authors followed up the neurodevelopmental 
outcome of this cohort of preterms at 18 and 21 
months and concluded that there was no statistically 
significant difference in the combined death or severe 
adverse neurodevelopmental outcome between the 
restrictive and the liberal transfusion groups.  
 
A number of non-transfusion approaches have 
been suggested, including cord blood collection
 
as a 
form of ‘autologous’ donation8 and delayed cord 
clamping (30s delay transfers 10-15mL/kg body 
weight of blood). Studies found lower rates of 
intraventricular hemorrhage and late-onset sepsis in 
the infants who underwent delayed cord clamping. In 
other studies, a delay in cord clamping of 30s resulted 
in improved iron status, fewer transfusions, and an 
association with improved neurodevelopmental 
outcomes.
10
 
Controversy still surrounds the use of 
erythropoietin (EPO) and erythropoiesis-stimulating 
agents.
11
 A Cochrane meta-analysis concluded that late 
administration of rhEPO (after the first postnatal 
week) reduced the number and volume of RCTs, but 
the clinical importance of this was considered 
marginal.
12
 In a second Cochrane meta-analysis 
comparing late with early (first postnatal week) 
administration of EPO, the authors reached similar 
conclusions and observed an increase in the risk of 
retinopathy of prematurity. They could not recommend 
early or late administration of EPO and suggested that 
future studies focus on methods for reducing donor 
exposure and phlebotomy losses.
13
 
Materno-fetal transfer of minerals, vitamins and 
iron mainly occurs in the last trimester of pregnancy 
therefore preterms become deficient rather easily. This 
fact, together with their higher requirements for 
growth and need to combat serious illness, makes 
adequate supplementation of vitamin B12, folate and 
iron important in preventing anaemia.  
 
Conclusion 
The introduction of a single donor programme for 
high-risk preterms would significantly reduce the 
number of donor units required by up to 65%. 
Furthermore, this study has shown that the provision 
of red cell aliquots of 50mls of blood would suffice 
and significantly reduce wastage in this limited 
resource. 
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Corinthia Group Prize in Paediatrics, 2013 
The Corinthia Group Prize in Paediatrics for 2013 was 
awarded to Dr Jessica Pace, who obtained the highest 
aggregate mark over the combined examinations in 
Paediatrics in the fourth and final year of the 
undergraduate course.  Whilst offering our 
congratulations to Dr Pace, we would also like to 
congratulate all those who performed admirably during 
the undergraduate course in Paediatrics, some of whom 
were only marginally ‘pipped to the post’ by Dr Pace. 
In the accompanying photograph, Dr Pace is seen 
receiving a cheque for €233 from Professor Simon 
Attard Montalto, Head of Paediatrics, in the Medical 
School Museum. Finally, the Academic Department of 
Paediatrics and Medical School remain indebted and are 
extremely grateful to the Corinthia Group for their 
ongoing support. 
 
Professor Simon Attard Montalto 
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